Skip to content

Multichannel Dysfunction Associated With a Dominant-Negative KCNH2 Missense Variant, p.G604S, Results in Action Potential Duration Prolongation and Early Afterdepolarizations in a Patient-Specific, Reengineered Cardiomyocyte Model of Type 2 Long-QT Syndrome.

Oct 2026 · Circulation: Arrhythmia and Electrophysiology · pp. e014919 · 0 citations · 29 references
Medicine

TL;DR

Fux dynamics analysis indicated that this persistent Ca2+ entry suppresses the forward-mode sodium-calcium exchanger, forcing a compensatory reliance on sarcoplasmic-endoplasmic reticulum Ca-ATPase that primes for calcium instability.

Abstract

Background

Type 2 long-QT syndrome results from KCNH2-encoded Kv11.1 loss-of-function, but whether secondary inward-current dysfunction amplifies dysfunction remains unclear.

Methods

We characterized sodium (SCN5A, INa) and L-type calcium channel (CACNA1C, ICa) function in KCNH2-G604S and variant-corrected isogenic control induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). Whole-cell patch-clamp measured action potential duration at 90% repolarization (APD90), and potassium (IKr), sodium (INa), and calcium (ICa, L) currents. Fluo-4 imaging quantified calcium transients. A modified Kernik-Clancy iPSC-CM model incorporated experimentally measured persistent INa,L and ICa,L fractions and simulated isolated and combined current defects.

Results

KCNH2-G604S caused severe IKr loss-of-function (72.5% reduction). APD90 was prolonged in G604S-iPSC-CMs (765±58 ms) compared with isogenic controls (368±37 ms; P<0.005), with early afterdepolarizations in 50% of G604S cells. Nifedipine, verapamil, and mexiletine successfully shortened APD90 and abolished early afterdepolarizations. Compared with isogenic control, INa,L (0.60±0.1% versus 0.26±0.06%; P<0.01), persistent ICa,L (2.88±0.55% versus 1.26±0.35%; P<0.05), and calcium transient decay times (P<0.0001) were greater in G604S iPSC-CMs. Increased persistent ICa,L was phenocopied by E-4031 in isogenic controls and reduced by nifedipine in G604S iPSC-CMs. In silico modeling revealed that the IKr defect alone prolonged APD90 to only 620 ms. The addition of the observed INa,L defect had a small additive effect (+20 ms); however, incorporating persistent ICa,L synergistically extended APD90 to 758 ms, replicating the experimental phenotype. Flux dynamics analysis indicated that this persistent Ca2+ entry suppresses the forward-mode sodium-calcium exchanger, forcing a compensatory reliance on sarcoplasmic-endoplasmic reticulum Ca-ATPase that primes for calcium instability.

Conclusions

The KCNH2-G604S variant drives a severe multihit phenotype via primary IKr loss-of-function and secondary state-dependent gain-of-function in persistent ICa,L. These comprehensive validations demonstrate that the remodeled persistent ICa,L acts as the essential amplifier driving extreme action potential duration prolongation and Ca2+ mishandling.

View source

Similar papers

Open access Oct 2026

NS1643 enhances the activity of T1019PfsX38 and Q1070X hERG channels associated with long QT syndrome type 2

It is concluded that the functions of T1019PfsX38- and Q1070X-hERG channels can be augmented by hERG potentiators if NMD is incomplete, which may facilitate the development of a mechanism-based rescue approach.

M. Al-Salmani, Amira Alkharusi, Mohammed Al-Rawahi et al. · 0 citations
Open access Oct 2026

The p.Arg52Leu variant in GNB2 causes a gain-of-function due to an increase of IK, ACh in stimulated hiPSC-CMs

Initially discovered and published in 2017, the heterozygous mutation (p.Arg52Leu) in the GNB2 gene is associated with sinus node dysfunction (SND) and atrioventricular block (AVB). Electrophysiological characterization using heterologous expression systems has demonstrated that this R52L GNB2 variant results in a larg...

A. Verkerk, Anne Kayser, Jassin Hamidi et al. · 0 citations
Open access Sep 2026

Functional and pharmacological characterization of the SCN2A variant p.C258R with mixed gain and loss of function causing developmental and epileptic encephalopathy type 11

Pathogenic variants in SCN2A cause dysfunction of the NaV1.2 voltage-gated sodium channel and are associated with neurodevelopmental disorders with or without epilepsy. Treatment of epilepsy in these patients is challenging and depends on whether the variant results in a gain (GoF) or loss of function (LoF). We describ...

Alina Köppel, H. de Vries, M. Jamili et al. · 0 citations
Open access Oct 2026

The ARumenamide AR-788 suppresses the transient outward current in human iPSC-derived right-ventricular Brugada cardioids

Brugada syndrome (BrS) is an inherited arrhythmia disorder with limited drug therapy, quinidine being the principal agent. Loss-of-function variants in SCN5A reduce the cardiac sodium current (INa), but the arrhythmogenic imbalance also depends on the transient outward potassium current (Ito). Here we generated human i...

Y. Guéret, A. Girardeau, S. Godin et al. · 0 citations
Open access Sep 2026

Functional heterogeneity of arrhythmogenic KCNQ1 S1 mutants reveals dependence on the number of KCNE1 subunits in the IKs channel complex.

BACKGROUND A cluster of closely spaced residues located at the extracellular end of the S1 transmembrane domain in KCNQ1 (Q1, residues 140-147) harbors six mutations associated with both gain- and loss-of-function (GoF and LoF) arrhythmic diseases. Whether severity of the mutation phenotype is affected by the stoichiom...

Michael Tian, M. Pourrier, Magnus Chan et al. · 0 citations
Open access Sep 2026

Variable Expressivity in Long QT Syndrome Type 2 Rabbits Defines a Low Threshold for Therapeutic IKr Restoration

Long QT syndrome type 2 (LQT2) is caused by pathogenic variants in the hERG potassium channel, resulting in QT prolongation, polymorphic ventricular tachycardia (pVT), and sudden cardiac death. We previously developed a transgenic LQT2 rabbit model that recapitulates the human disease and segregates into two phenotypic...

N. Turan, Allison Welton, Yi-Chun Lu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.